Art. 5 Directive (EU) 2001/83

In forcesince 26 Jan 2007cited 45×
1.

A Member State may, in accordance with legislation in force and to fulfil special needs, exclude from the provisions of this Directive medicinal products supplied in response to a bona fide unsolicited order, formulated in accordance with the specifications of an authorised health-care professional and for use by an individual patient under his direct personal responsibility.

2.

Member States may temporarily authorise the distribution of an unauthorised medicinal product in response to the suspected or confirmed spread of pathogenic agents, toxins, chemical agents or nuclear radiation any of which could cause harm.

3.

Without prejudice to paragraph 1, Member States shall lay down provisions in order to ensure that marketing authorisation holders, manufacturers and health professionals are not subject to civil or administrative liability for any consequences resulting from the use of a medicinal product otherwise than for the authorised indications or from the use of an unauthorised medicinal product, when such use is recommended or required by a competent authority in response to the suspected or confirmed spread of pathogenic agents, toxins, chemical agents or nuclear radiation any of which could cause harm. Such provisions shall apply whether or not national or Community authorisation has been granted.

4.

Liability for defective products, as provided for by Council Directive 85/374/EEC of 25 July 1985 on the approximation of the laws, regulations and administrative provisions of the Member States, concerning liability for defective products [OJ L 210, 7.8.1985, p. 29. Directive as last amended by Directive 1999/34/EC of the European Parliament and of the Council (OJ L 141, 4.6.1999, p. 20).], shall not be affected by paragraph 3.

The 10 that are cited most themselves, of 45.

  • Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 20…83Law

    … Настоящият член не засяга разпоредбите на Директива 2001/20/ЕО и член 5 от Директива 2001/83/ЕО.

  • Judgment of the Court (Third Chamber), 29 March 2012. European Commission v Republic of Poland.Decision

    Directive 2001/83 provides, however, for derogations from that general rule laid down in Article 6(1). It is common ground that only the derogation referred to in Article 5(1) of that directive is relevant to the present case.

    29 Mar 2012 · 62010CJ0185

  • Judgment of the Court (Second Chamber) of 8 November 2007. Ludwigs - Apotheke München Internationale Apotheke v Juers Pharma Import-Export GDecision

    The Court finds that, even if the power to make such a derogation is not expressly granted by Directive 2001/83, that derogation is not necessarily contrary to that directive provided that it is applied so as not to undermine the general …

    8 Nov 2007 · 62006CJ0143

  • Directive (EU) 2004/27Lawamends

  • Judgment of the Court (Fourth Chamber), 11 April 2013. Novartis Pharma GmbH v Apozyt GmbH.Decision

    Article 5(1) of the directive provides: ‘A Member State may, in accordance with legislation in force and to fulfil special needs, exclude from the provisions of this Directive medicinal products supplied in response to a bona fide …

    11 Apr 2013 · 62011CJ0535

  • Judgment of the Court (Grand Chamber) of 23 January 2018. F. Hoffmann-La Roche Ltd and Others v Autorità Garante della Concorrenza e del MerDecision

    The Consiglio di Stato (Council of State) decided to stay the proceedings and to refer the following questions to the Court for a preliminary ruling: On a proper construction of Article 101 TFEU, can the parties to a licensing agreement be …

    23 Jan 2018 · 62016CJ0179

  • Judgment of the Court (Third Chamber) of 16 July 2015. Abcur AB v Apoteket Farmaci AB and Apoteket AB.Decision

    Article 5(1) of Directive 2001/83 provides: ‘A Member State may, in accordance with legislation in force and to fulfil special needs, exclude from the provisions of this Directive medicinal products supplied in response to a bona fide …

    16 Jul 2015 · 62013CJ0544

  • CASE OF HRISTOZOV AND OTHERS v. BULGARIADecision

    … Poland argued that its domestic law complied with the derogation envisaged by Article 5(1) of Directive 2001/83/EC. In a judgment of 29 March 2012, the Court of Justice held that by allowing the importation and placing on the market of …

    13 Nov 2012 · 001-114492

  • Opinion of Advocate General Sharpston delivered on 31 January 2013. Novartis Pharma GmbH v Apozyt GmbH.Decision

    By virtue of Article 5(1): ‘A Member State may, in accordance with legislation in force and to fulfil special needs, exclude from the provisions of this Directive medicinal products supplied in response to a bona fide unsolicited order, …

    31 Jan 2013 · 62011CC0535

  • Décret n° 2014-1703 du 30 décembre 2014 modifiant les règles relatives à l'élaboration d…Law

    … du 6 novembre 2001 modifiée instituant un code communautaire relatif aux médicaments à usage humain, notamment son article 5, Vu le code de la santé publique, notamment son article L. 5121-12-1 ; Le Conseil d'Etat (section sociale) …